Skip to content

Clinical analysis of central nervous system lymphoma in children

Clinical analysis of childhood lymphoma with central nervous system involvement

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096224
Enrollment
Unknown
Registered
2025-01-20
Start date
2025-01-20
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphoma

Interventions

Children's lymphoma:None

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. 0~18 years old; 2. The clinical manifestations were consistent with lymphoma, and the histomorphology and immunotype were confirmed as lymphoma by pathological biopsy or fluid cytology examination; 3. Children who were newly diagnosed between January 1, 2013 and August 31, 2024 (who had not received any lymphoma-related treatment before coming to the hospital); 4. After diagnosis, he received standardized treatment in our hospital and kept complete clinical data; 5. Combined with clinical manifestations and auxiliary examination, comprehensive judgment can be made to determine whether there is central nervous system involvement.

Exclusion criteria

Exclusion criteria: 1. Incomplete clinical data; 2. Patients who do not receive standardized treatment in our hospital due to personal non-medical reasons.

Design outcomes

Primary

MeasureTime frame
1-year event-free survival rate;

Secondary

MeasureTime frame
Incidence of central nervous system involvement in children with different pathological types of lymphoma;Analysis of prognostic factors of central nervous system involvement;

Countries

China

Contacts

Public ContactPanpan Zhou

Qilu Hospital of Shandong University

956692408@qq.com+86 18560083681

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026